The Tuberculosis Clinical Diagnostics Research Consortium (CDRC) evaluates diagnostic tests and strategies in tuberculosis (TB) endemic countries. These efforts are supported by clinicians familiar with the process for diagnosis or exclusion of TB. CDRC sites serve diverse populations of patients, including HIV-positive and negative patients, pediatric patients, and patients with other co-infections and co-morbid conditions. The CDRC also provides information to the greater community of TB investigators about TB diagnostic development.
Last Updated November 16, 2015